CY1106086T1 - Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα - Google Patents

Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Info

Publication number
CY1106086T1
CY1106086T1 CY20061100500T CY061100500T CY1106086T1 CY 1106086 T1 CY1106086 T1 CY 1106086T1 CY 20061100500 T CY20061100500 T CY 20061100500T CY 061100500 T CY061100500 T CY 061100500T CY 1106086 T1 CY1106086 T1 CY 1106086T1
Authority
CY
Cyprus
Prior art keywords
methylon
androgens
beta
substituted
preparation
Prior art date
Application number
CY20061100500T
Other languages
Greek (el)
English (en)
Inventor
Dirk Leysen
Jaap Van Der Louw
Roberta Buma Bursi
Marcel Evert De Gooyer
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1106086T1 publication Critical patent/CY1106086T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20061100500T 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα CY1106086T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02
EP00993259A EP1237904B1 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (1)

Publication Number Publication Date
CY1106086T1 true CY1106086T1 (el) 2011-06-08

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100500T CY1106086T1 (el) 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Country Status (27)

Country Link
US (1) US6706700B2 (cg-RX-API-DMAC10.html)
EP (1) EP1237904B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003515543A (cg-RX-API-DMAC10.html)
CN (1) CN1166680C (cg-RX-API-DMAC10.html)
AR (1) AR026655A1 (cg-RX-API-DMAC10.html)
AT (1) ATE317396T1 (cg-RX-API-DMAC10.html)
AU (1) AU778017B2 (cg-RX-API-DMAC10.html)
CA (1) CA2390226A1 (cg-RX-API-DMAC10.html)
CO (1) CO5251441A1 (cg-RX-API-DMAC10.html)
CY (1) CY1106086T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ301376B6 (cg-RX-API-DMAC10.html)
DE (1) DE60025958T2 (cg-RX-API-DMAC10.html)
DK (1) DK1237904T3 (cg-RX-API-DMAC10.html)
ES (1) ES2258037T3 (cg-RX-API-DMAC10.html)
HK (1) HK1047596B (cg-RX-API-DMAC10.html)
HU (1) HUP0203611A3 (cg-RX-API-DMAC10.html)
IL (1) IL149424A (cg-RX-API-DMAC10.html)
MX (1) MXPA02004939A (cg-RX-API-DMAC10.html)
NO (1) NO322422B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ518753A (cg-RX-API-DMAC10.html)
PE (1) PE20011033A1 (cg-RX-API-DMAC10.html)
PL (1) PL202999B1 (cg-RX-API-DMAC10.html)
RU (1) RU2242479C2 (cg-RX-API-DMAC10.html)
SK (1) SK287095B6 (cg-RX-API-DMAC10.html)
TW (1) TWI275593B (cg-RX-API-DMAC10.html)
WO (1) WO2001040255A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200203536B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
EP1470151B1 (en) * 2002-01-21 2009-12-30 N.V. Organon Process for the preparation of 7-alpha-methylsteroids
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
AU2012320423C1 (en) * 2011-10-07 2018-01-25 Estetra Srl Process for the production of estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Also Published As

Publication number Publication date
NO20022564D0 (no) 2002-05-30
NO322422B1 (no) 2006-10-02
IL149424A (en) 2007-05-15
ZA200203536B (en) 2003-08-04
CN1402735A (zh) 2003-03-12
US6706700B2 (en) 2004-03-16
PL355689A1 (en) 2004-05-17
CZ20021894A3 (cs) 2002-08-14
AR026655A1 (es) 2003-02-19
CA2390226A1 (en) 2001-06-07
DE60025958D1 (de) 2006-04-20
HK1047596B (en) 2006-04-21
AU2838301A (en) 2001-06-12
CZ301376B6 (cs) 2010-02-03
PL202999B1 (pl) 2009-08-31
SK287095B6 (sk) 2009-12-07
NZ518753A (en) 2004-05-28
HK1047596A1 (en) 2003-02-28
SK7582002A3 (en) 2002-09-10
DE60025958T2 (de) 2006-07-27
RU2242479C2 (ru) 2004-12-20
HUP0203611A2 (hu) 2003-03-28
US20030100543A1 (en) 2003-05-29
WO2001040255A2 (en) 2001-06-07
WO2001040255A3 (en) 2001-11-15
JP2003515543A (ja) 2003-05-07
NO20022564L (no) 2002-05-30
MXPA02004939A (es) 2003-05-23
ATE317396T1 (de) 2006-02-15
CN1166680C (zh) 2004-09-15
EP1237904B1 (en) 2006-02-08
DK1237904T3 (da) 2006-06-06
PE20011033A1 (es) 2001-10-11
CO5251441A1 (es) 2003-02-28
HUP0203611A3 (en) 2004-07-28
TWI275593B (en) 2007-03-11
AU778017B2 (en) 2004-11-11
ES2258037T3 (es) 2006-08-16
IL149424A0 (en) 2002-11-10
EP1237904A2 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
PL351954A1 (en) Indoline derivatives as progesterone antagonists
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
AP1414A (en) Controlled release galantamine composition.
MXPA03000065A (es) Composiciones de micelas polimericas.
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
CY1106463T1 (el) Τοπικη ορμονικη συνθεση με συστημικο αποτελεσμα
CY1105931T1 (el) Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας
ECSP083351A (es) Composiciones farmacéuticas
TR200101826T2 (tr) Üç-fazlı ağızdan alınan gebelik önleyici ilaç
NZ514574A (en) Novel method of treatment
AU2740797A (en) Androstene derivatives
CY1110637T1 (el) Διαδερμικο συστημα παραδοσης ορμονων χωρις ενισχυτες διεισδυσης
WO2001040255A3 (en) 14,15-beta-methylene substituted androgens
IL139861A0 (en) 17β-AMINO-AND HYDROXYLAMINO -11 β-ARYLSTEROID DERIVATIVES, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
ATE225800T1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
HUP9903747A2 (hu) Új eljárás mometazon-furoát előállítására
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
AR022852A1 (es) Nuevos androgenos
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.